Toggle light / dark theme

A strategy of microglia replacement alleviates microgliopathy in a CSF1R I794T hotspot mutation mouse model of CSF1R-related disorder

Microglial replacement strategy to treat microgliopathy.

Colony-stimulating factor 1 receptor (CSF1R) gene mutation (I794T) is linked to primary microgliopathy manifesting as leukoencephalopathy.

The researchers define the clinical features of patients carrying the CSF1R p. I794T variant and establish a corresponding knockin mouse model.

The authors demonstrate that knockin mice exhibited hallmark features of CSF1R-related disorder (CSF1R-RD).

They show that Csf1rI792T/+ microglia adopt a disease associated state and that a microglial replacement strategy termed “duplicate-cyclic microglial depletion for transplantation” (DCMDT), mitigates cognitive and neuropathological deficits in CSF1R-RD. sciencenewshighlights ScienceMission https://sciencemission.com/microglia-replacement-18450


Li et al. define the clinical features of patients carrying the CSF1R p. I794T variant and establish a corresponding knockin mouse model. They show that Csf1rI792T/+ microglia adopt a disease-associated state and that a microglial replacement strategy, DCMDT, mitigates cognitive and neuropathological deficits in CSF1R-related disorder.

Mechanism of Viral DNA Packaging in Phage T4 Using Single-Molecule Fluorescence Approaches

📊 Research Summary: The ImmunoSep trial demonstrates the potential for biomarker-guided immunotherapy in a subset of patients with sepsis.


This trial assessed whether immunotherapy tailored to individual immune dysregulation—macrophage activation–like syndrome and sepsis-induced immunoparalysis—could improve organ function among patients with sepsis-3.

Triglycerides induce endoplasmic reticulum lipid bilayer stress to activate PERK and enhance antifungal immunity

Fungal infections present persistent therapeutic challenges in immunocompromised populations, including individuals with acquired immunodeficiency syndrome (AIDS), organ transplant recipients receiving immunosuppressive therapy, long-term hospitalized patients, patients with cancer, and those receiving immunomodulatory agents.1 These infections demonstrate remarkable recalcitrance to conventional therapies, compounded by fungal adaptability to environmental stresses, the emergence of drug-resistant strains, and the limited availability of clinically available antifungal agents.2 Systemic fungemia has alarmingly high mortality rates, accounting for approximately 1.5 million annual deaths worldwide, a burden comparable to AIDS-and tuberculosis-related mortality.3 Candida albicans is the most frequently isolated fungal pathogen in clinical settings. Despite therapeutic advances, invasive candidiasis persists with mortality rates exceeding 40%,4 underscoring the urgent need to elucidate host immune mechanisms against fungal pathogens.

When innate immune cells, such as macrophages, dendritic cells, and neutrophils, encounter fungi, the pattern recognition receptors (PRRs) on their surface recognize evolutionarily conserved fungal cell wall components, including β-glucan and α-mannan (classified as pathogen-associated molecular patterns), thereby initiating downstream signaling cascades and immune responses. The primary PRRs involved in fungal recognition are C-type lectin receptors (CLRs) and Toll-like receptors. The CLR family comprises Dectin-1 (specific for β-glucan), Dectin-2/3 (mannan sensors), Mincle, dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin, and CD23.5 Upon ligand binding, CLRs initiate the phosphorylation of the immunoreceptor tyrosine-based activation motif within the Dectin-1 cytoplasmic tail and the recruitment of the Fc receptor γ-chain to Dectin-2 or Mincle, which serves as a docking site for spleen tyrosine kinase (SYK).

Circadian rhythm heterogeneity modulates drug response variations in neuroblastoma models

Ector et al. uncover circadian heterogeneity across neuroblastoma cell models and link rhythmic strength to drug sensitivity. Their findings suggest that circadian competence may influence treatment outcomes, pointing to chronotherapy as a potential avenue for improving pediatric cancer care.

Electrohydrodynamic bioprinting creates living muscle tissues with tightly aligned cells inside

Building functional human muscle in the laboratory has long been a goal of regenerative medicine, but one stubborn obstacle remains: real muscle is not just a mass of cells. Its strength and function depend on exquisitely ordered myofibers, all aligned in precise directions that vary from one muscle to another. Reproducing that internal order has proved far harder than shaping muscle tissue into the right external form.

Published in the International Journal of Extreme Manufacturing, a research team from Xi’an Jiaotong University has now found a way to solve both problems at once. By using electric forces during the electrohydrodynamic bioprinting process, they have created living muscle tissues whose cells naturally line up just as they do in the human body, showing how electric forces can be used not just to precisely bioprint tissue, but to quietly instruct cells how to organize themselves.

Skeletal muscles come in many forms. Some fibers run in long, parallel bundles that power our arms and legs. Others curve or fan out, helping us grip, chew or control movement with precision. Despite these differences, all muscles share a common microscopic feature: their cells are highly aligned. This alignment allows individual muscle cells to fuse into long fibers and contract efficiently. Without it, muscle tissue is weak and poorly functional.

Andrew Yang: UBI Before UHI

Solving Job Loss, and the Future of Work ## Andrew Yang advocates for the implementation of Universal Basic Income (UBI) as a necessary solution to address job loss, income inequality, and societal unrest caused by technological advancements and AI-driven changes in the economy ## ## Questions to inspire discussion.

Universal Basic Income Implementation.

🔹 Q: What UBI amount should be set to provide an effective safety net?

A: UBI should be set at twice the poverty level, around $25,000 per person per year, providing enough for survival but not happiness to maintain work incentives while protecting against economic collapse.

🔹 Q: How can UBI be funded without government action initially?

A: Well-resourced tech billionaires could fund UBI directly to local communities to keep the middle class afloat during AI-driven changes, potentially catalyzing further philanthropy and government action.

Robotic surgery removes hard-to-reach caudate lobe tumor in a 79-year-old

Resection of tumors in the caudate lobe (a deep, hard-to-reach part of the liver) is recognized as one of the most technically challenging procedures in hepatic surgery due to its unique anatomical position and complex vascular relationships. Researchers at Boston University Chobanian & Avedisian School of Medicine now show that it is possible to remove the caudate lobe safely using a surgical robot, even in an older patient, and still remove the cancer completely.

The clinical case they describe in the journal Annals of Surgical Oncology, combines two “guidance” tools: a hanging/traction technique using the Arantius ligament and Indocyanine green (ICG) “negative staining” to clearly mark the caudate lobe boundaries and guide a margin-focused cancer operation in a very difficult area.

“The caudate lobe is one of the most technically demanding areas of the liver—it’s deep and surrounded by critical vessels,” said corresponding author Eduardo Vega, MD, assistant professor of surgery. “Robotic surgery can help us remove select tumors through smaller incisions, with less pain and blood loss and quicker recovery, while still aiming for cure.”

Senovax takes a novel approach

Senescent “zombie” cells accumulate as we age, releasing inflammatory signals that damage surrounding tissue. Senovax takes a novel approach: train the immune system to recognize these cells and eliminate them. By exposing dendritic immune cells to lab-generated senescent cells, the body learns the markers that identify aging cells. The result: the immune system creates a “wanted poster” and begins targeting senescent cells throughout the body. Unlike drugs that must reach specific tissues, the immune system already travels everywhere — and it remembers. One treatment could potentially provide long-lasting protection.

Read more

/* */